Welcome to our dedicated page for Canopy Growth news (Ticker: CGC), a resource for investors and traders seeking the latest updates and insights on Canopy Growth stock.
Canopy Growth Corporation (CGC) generates a steady flow of news as a cannabis-focused manufacturer with operations spanning medical and adult-use markets, branded products, and vaporization devices. The Canopy Growth news page on Stock Titan aggregates these disclosures so readers can follow how the company’s strategy, financing, and operations evolve over time.
Company news frequently covers financial performance and capital structure. Canopy Growth issues quarterly results releases that discuss cannabis and Storz & Bickel net revenue, segment performance in Canada and international markets, gross margins, operating loss, adjusted EBITDA, and free cash flow, along with commentary on cost management and balance sheet strength. The company also announces financing transactions, such as term loan agreements, prepayments on senior secured debt, convertible debenture exchanges, and at-the-market equity programs.
Another major category of news involves corporate transactions and governance. Canopy Growth has reported entering into an arrangement agreement to acquire MTL Cannabis Corp., detailing consideration, required approvals, and expected strategic benefits. It also publishes results of its annual general and special meetings, including director elections, auditor appointments, share consolidation authority, and advisory votes on executive compensation, as well as updates on board and executive appointments.
Product and market updates are a recurring theme. The company announces launches such as Claybourne Gassers liquid diamonds All-in-One vapes and Claybourne Frosted Flyers infused pre-roll variety packs in Canada, along with expansions of the Spectrum Therapeutics medical portfolio in Australia through new softgel formats. It also highlights operational moves like dedicating the DOJA facility in Kelowna to medical cultivation for Spectrum Therapeutics patients.
Investors and observers who monitor CGC news can use this page to track developments in Canopy Growth’s Canadian adult-use and medical businesses, its international medical operations in Europe and Australia, its indirect exposure to the U.S. THC market through Canopy USA, and its ongoing efforts to manage debt, liquidity, and governance matters. Bookmark this feed to review new press releases, transaction updates, and regulatory communications as they are published.
On July 27, 2021, Canopy Growth Corporation (NASDAQ: CGC) announced the launch of Tweed Quickies and Ace Valley Pinners, two new lines of smaller pre-roll joints available in larger pack sizes. This move responds to consumer preferences for more manageable cannabis options, particularly in social settings. Tweed Quickies, featuring 0.35 gram joints, come in packs of ten, while Ace Valley Pinners offer 0.3 gram joints in packs of eight. The products are designed for individual or group use without sharing, marking a significant addition to Canopy's product portfolio during the summer.
Canopy Growth Corporation (TSX: WEED, NASDAQ: CGC) will announce its financial results for Q1 fiscal year 2022 on August 6, 2021. This includes earnings for the period ended June 30, 2021. An audio webcast with CEO David Klein and CFO Mike Lee will follow the results at 10:00 AM ET on the same day. Investors can access the webcast live and as a replay until November 4, 2021. Canopy Growth remains a leader in the cannabis sector, with a focus on consumer wellness and diverse product offerings.
Canopy Growth Corporation has successfully completed its acquisition of The Supreme Cannabis Company, Inc. as of June 23, 2021. This strategic move enhances Canopy's leadership in the Canadian recreational cannabis market, increasing its market share to 18.1%. The acquisition includes Supreme's low-cost cultivation facility in Kincardine, Ontario, and is expected to yield $30 million in synergies within two years. As part of the Arrangement, Supreme shareholders receive 0.01165872 Canopy shares and $0.0001 in cash for each Supreme share.
Little Green Pharma Ltd has acquired a GMP medicinal cannabis cultivation and manufacturing facility in Denmark from Canopy Growth Corporation for C$20 million. The facility can produce over 12 tonnes of medicinal cannabis annually and enhances LGP's inventory, which currently holds about 1 tonne. This strategic acquisition allows LGP to expand into EU and global markets, with immediate plans to deliver products in Australia and Germany. The facility is expected to begin offering registered medicinal products in Denmark by early 2022, positioning LGP as a leader in the Australian medicinal cannabis sector.
Canopy Growth Corporation reported a 37% revenue growth for FY 2021, reaching $546.6 million, with significant gains in both cannabis and consumer products. The company maintains its leading position in the Canadian flower market and is making strides in the US market with new product launches, including CBD products by Martha Stewart. Canopy aims for positive Adjusted EBITDA in H2 FY 2022 and expects cost savings of $150-$200 million within 18 months. However, the company reported a net loss of $1.67 billion for the fiscal year.
On May 28, 2021, Canopy Growth Corporation (NASDAQ: CGC) announced participation in upcoming investor conferences in June 2021. Executives David Culver and Judy Hong will take part in the Piper Sandler Consumer Marketplace Conference on June 3, discussing legalization and regulatory landscapes. Rade Kovacevic will present at the Oppenheimer Consumer Growth and E-Commerce Conference on June 15, focusing on consumer insights and product innovation. Both events will be accessible via live webcast on the company's website, with replays available for 90 days.
Canopy Growth Corporation (CGC) appoints Martha Stewart as its official strategic advisor to enhance its product innovation and branding strategies. In her new role, she will provide expert counsel on product development and strategic partnerships. This appointment follows the successful launch of the Martha Stewart CBD product line, which includes wellness supplements for both humans and pets. The brand has seen significant consumer demand, with products selling out for holidays. Additionally, Canopy Growth has secured a distribution deal with Southern Glazer's Wine and Spirits to expand the reach of Martha Stewart CBD across the U.S.
Canopy Growth Corporation (TSX: WEED, NASDAQ: CGC) will announce its financial results for the fourth quarter and fiscal year 2021, concluding on March 31, 2021, before markets open on June 1, 2021. Following this announcement, a live audio webcast featuring CEO David Klein and CFO Mike Lee will take place at 10:00 AM ET on the same day. Investors can access the webcast and replay until August 30, 2021. Canopy Growth is a leading cannabis company, known for its diverse product offerings and partnerships, including one with Constellation Brands.
Canopy Growth Corporation (NASDAQ: CGC) has entered a partnership with Southern Glazer's Wine & Spirits to distribute its CBD-infused beverage, Quatreau, across the U.S. This agreement allows Canopy to leverage Southern Glazer's extensive distribution network, aiming to enhance market access for its CBD product line beginning in seven states. Quatreau, priced at $3.99 per 12-ounce can, offers 20 mg of U.S.-grown hemp-based CBD in four flavors and follows its successful launch in Canada. This move highlights Canopy's strategy to expand its presence in the booming CBD beverage market.
Canopy Growth Corporation announced a definitive agreement to acquire The Supreme Cannabis Company for approximately $435 million, offering Supreme shareholders a 66% premium per share. The deal enhances Canopy's brand portfolio by adding 7ACRES and strengthens its market position, potentially increasing its Canadian recreational market share to 13.6%. The acquisition is expected to yield cost synergies of $30 million within two years and expand Canopy's footprint in the U.S. CBD market. Shareholder approval is anticipated by June 2021.